Green Cross Lab Cell Corp operates in the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Green Cross Lab Cell Corp with three other
health care providers in Asia:
Human Health Holdings Ltd
of HONG KONG
sales of 528.59 million Hong Kong Dollars [US$68.20 million]
of which 64%
was General practice services),
(18.99 million Singapore Dollars [US$13.98 million]
Cordlife Group Limited
based in SINGAPORE
(61.58 million Singapore Dollars [US$45.35 million]
of which 97%
Green Cross Lab Cell Corp reported sales of 57.90 billion Korean Won (US$51.30 million)
December of 2019.
increase of 14.4%
versus 2018, when the company's sales were 50.62 billion Korean Won .
Sales at Green Cross Lab Cell Corp have increased during each of the previous five years
(and since 2014, sales have increased a total of 87%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
282.9% in 2019, from
102.37 million Korean Won to 391.96 million Korean Won .
Green Cross Lab Cell Corp also saw significant increases in sales in
Clinical Trial (up 36.9% to 5.54 billion Korean Won )
Merchandise Sales (up 53.9% to 3.18 billion Korean Won )
Not all segments of Green Cross Lab Cell Corp experienced an increase in sales in 2019:
sales of Cord Blood Storage Service fell 35.2% to 1.08 billion Korean Won .
(However, this segment's sales were only a very small portion of the company's overall sales).
Green Cross Lab Cell Corp also experienced decreases in sales in
Bio Logistics (down 17.4% to 4.07 billion Korean Won )